Is this the next CSL?

Read the article "Beautiful Blood: How CSL became a global success story" in the SMH.
disallowed/business/markets/beautiful-blood-how-csl-became-a-global-success-story-20180601-p4zis1.html
If the link doesn't work simply Google "How did CSL become so big?"

CSL listed in 1994 with a market value of $299 million, at $2.30 a share (equivalent to 81¢ today). Today, CSL shares are trading at $289 with a MC of AUD$131.4 billion.

CSL's major strength are its plasma products. "They are made from human blood,” The market, because of population growth, continues to expand. Blood plasma's are used to treat people who need transfusions - a small proportion of the population..

BD1's main products (albeit not yet in market) are cancer detection and screening tools to routinely test otherwise perfectly healthy people.

There are way more healthy people in the world compared to the number who need transfusions.

Funnily enough, BD1 based in Melbourne need only walk down the road and talk to CSL and make a license deal. CSL has global distribution.

CSL's success has mostly been from technologies acquired from other research organisations. They are always looking for the next big thing.

CSL Share Price History: